The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million

Mon, 01st Jun 2020 11:16

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Fuller Smith & Turner PLC - pubs - To issue commercial paper under Covid Corporate Financing facility for initial sum of GBP100 million, allowing GBP155 million revolving credit facility to remain undrawn. Placed 96% of employees on furlough, while executives and board members volunteered for pay reduction.

----------

Arricano Real Estate PLC - property - All five shopping centres in Ukraine open with effect on Saturday last week, as restrictions by local authorities on access to shopping centres lifted. However, food courts, cinema and entertainment centres will remain closed.

----------

Topps Tiles PLC - tile retail - To sale and leaseback head office in Enderby, Leicester, to UK Warehouse Properties Ltd for GBP18.1 million. Proceeds expected to strengthen group's financial position in the face of the Covid-19 crisis.

----------

Mattioli Woods PLC - wealth management - Annual revenue to be ahead of GBP58.5 million reported the year before. Profit to be ahead of management expectations. Directors to take 50% reduction in salaries and fees until end of June, while chief executive officer takes no salary at all. Group in strong financial position following the acquisition of Hurley Partners in March.

----------

Motif Bio PLC - cash shell - Remains in negotiations with several reverse takeover candidates in the healthcare sector, as the pandemic creates new opportunities for healthcare firms.

----------

CloudCall Group PLC - communications - Expects to have enough cash to fund it through period of macroeconomic uncertainty. Continues to report ongoing challenges within the broader marketplace, which has near-term impact on the sales pipeline. Year-to-date sales bookings from new customers 28% less than same period the year before.

----------

Zoetic International PLC - cannabidiol - Signs distribution agreement with partner BettermentRS to market tobacco-alternative Chill products to its network of outlets. Rollout of Chill brand delayed by pandemic, as many retail outlets closed on lockdown restrictions.

----------

MJ Hudson Group PLC - asset management - Reports strong sales activity and levels of client work during lockdown period. Confident in achieving profit for year ending June 30 in line with market expectations, despite revenue disruption due to the lack of new fund launch activity.

----------

Marshall Motor Holdings PLC - cars - Trading significantly ahead of UK market in first quarter of 2020. As lockdown eases, group gradually expanded its offering of aftersales services, with initial demand encouraging. Furloughed 90% of employees during lockdown period as many stores closed. To post a pretax loss for the first half of 2020.

----------

Braveheart Investment Group PLC - investments - Subsidiary Paraytec Ltd to launch project with University of Sheffield to develop a rapid test for Covid-19 test, which will utilise highly sensitive light-based detection system coupled with a molecular "affinity" device to capture Covid-19 virus particles. Paraytec to own all foreground intellectual property generated by the project.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
10 Oct 2019 11:52

Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial

Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial

Read more
2 Oct 2019 11:59

Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure

Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure

Read more
1 Oct 2019 17:09

Motif Bio To Become Cash Shell If Restructuring Proposals Accepted

Motif Bio To Become Cash Shell If Restructuring Proposals Accepted

Read more
2 Sep 2019 11:39

Motif Bio Delays Next Amortisation Date Of Hercules Loan Facility

(Alliance News) - Novel antibiotics-focused biopharmaceutical company Motif Bio PLC said Monday it has agreed with Hercules Capital Inc to postpone the next amortisation date for its loan and date

Read more
19 Aug 2019 10:46

WINNERS & LOSERS SUMMARY: IXICO Rises On Positive Outlook

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------J up 3.8%. The is

Read more
19 Aug 2019 09:29

Motif Bio Receives US State Funding For Iclaprim Listeria Study

(Alliance News) - Biopharmaceutical firm Motif Bio PLC said Monday that the US government will fund a study on the effectiveness of the iclaprim drug against listeria monocytogenes.Shares a

Read more
1 Aug 2019 11:43

Motif Bio Postpones Next Amortisation Date Of Hercules Loan Facility

(Alliance News) - Biopharmaceutical firm Motif Bio PLC said on Thursday has amended its loan agreement with Hercules Capital Inc, delaying the next amortisation date by one month to September a to

Read more
12 Jun 2019 18:16

Amphion Innovations To Work With Debt Providers To Refinance Facility

(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the in at

Read more
6 Jun 2019 10:47

WINNERS & LOSERS SUMMARY: Rolls Royce And L&G Rise On Pension Pact

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rolls up

Read more
31 May 2019 15:32

Motif Bio Shareholders Reject Remuneration Report Resolution

LONDON (Alliance News) - Motif Bio PLC on Friday said that shareholders voted against approval of the company's remuneration report.At the clinical-stage biopharmaceutical firm's on

Read more
1 May 2019 10:46

Motif Bio to work with Lamellar on cystic fibrosis treatment possibility

(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with Lamellar Biomedical, under which Motif Bio would conduct an in vivo preclinical study evaluating iclaprim in combination with Lamellar's patented 'Lamellasome' technology.

Read more
1 May 2019 09:26

Motif Bio Shares Up On Agreement With Lamellar To Start Clinical Study

LONDON (Alliance News) - Shares rose in Motif Bio PLC on Wednesday as it signed an agreement with Lamellar Biomedical to study the combination of Motif's iclaprim with Lamellar's in the at

Read more
26 Apr 2019 14:09

Motif Bio Appoints Andrew Powell As Non-Executive Director

LONDON (Alliance News) - Motif Bio PLC, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, said Friday it has appointed Andrew Powell as non-executive has as

Read more
15 Apr 2019 10:50

Motif Bio 2018 Loss Narrows As Research Costs Fall Despite US Delay

LONDON (Alliance News) - Motif Bio PLC said Monday its 2018 loss narrowed significantly as research costs fell, despite an unexpected delay in its new drug application in the US.In 2018, to

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.